Peter Kletting

Albert Einstein Allee 23
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation.

Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation.

Journal: Cancers
Published: June 20, 2023

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225.

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225.

Journal: EJNMMI research
Published: June 06, 2022

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice.

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice.

Journal: Pharmaceutics
Published: October 15, 2021

Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.

Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.

Journal: PloS one
Published: August 20, 2021

A Whole-Body Physiologically Based Pharmacokinetic Model for Alpha Particle Emitting Bismuth in Rats.

A Whole-Body Physiologically Based Pharmacokinetic Model for Alpha Particle Emitting Bismuth in Rats.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 29, 2021

A population-based method to determine the time-integrated activity in molecular radiotherapy.

A population-based method to determine the time-integrated activity in molecular radiotherapy.

Journal: EJNMMI physics
Published: June 10, 2021

Mathematical Modeling of In Vivo Alpha Particle Generators and Chelator Stability.

Mathematical Modeling of In Vivo Alpha Particle Generators and Chelator Stability.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 22, 2021

An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligands.

An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligands.

Journal: Nuklearmedizin. Nuclear medicine
Published: November 02, 2020

Comparison of MRI-based and PET-based image pre-processing for quantification of 11C-PBB3 uptake in human brain.

Comparison of MRI-based and PET-based image pre-processing for quantification of 11C-PBB3 uptake in human brain.

Journal: Zeitschrift fur medizinische Physik
Published: March 30, 2020

Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry.

Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry.

Journal: EJNMMI physics
Published: March 17, 2020

Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.

Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 13, 2020

The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model.

The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model.

Journal: Scientific reports
Published: October 01, 2019
Showing 1-12 of 29

Last Updated: 09/26/2026